Publications of Institute of Radiooncology - OncoRay (from 2013)

187 Publications
Therapeutic options to overcome tumor hypoxia in radiation oncology
Troost, E.; Koi, L.; Yaromina, A.; Krause, M.
Corresponding author: Troost, Egc HZDR, OncoRay, TUD, DKTK, NCT

Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy
Wijsman, R.; Dankers, F. J. W. M.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L.-F.; Bussink, J.
Corresponding author: Wijsman, R. UMCN

Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data
Lühr, A.; Löck, S.; Jakobi, A.; Stützer, K.; Bandurska-Luque, A.; Vogelius, I. R.; Enghardt, W.; Baumann, M.; Krause, M.
Corresponding author: Lühr, A. DKTK, OncoRay, DKFZ, HZDR

EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: a preclinical trial in 10 HNSCC-tumour-xenograft models
Koi, L.; Löck, S.; Linge, A.; Thurow, C.; Hering, S.; Baumann, M.; Krause, M.; Gurtner, K.
Corresponding author: Gurtner, Kristin TU Dresden

Dual-energy CT based proton range prediction in head and pelvic tumor patients
Wohlfahrt, P.ORC; Möhler, C.ORC; Stützer, K.; Greilich, S.; Richter, C.

Melanoma Brain Metastases
Brütting, J.; Rauschenberg, R.; Troost, E. G. C.; Meier, F.; Garzarolli, M.

Evaluation of stopping-power prediction by dual- and single-energy computed tomography in an anthropomorphic ground-truth phantom
Wohlfahrt, P.ORC; Möhler, C.ORC; Richter, C.; Greilich, S.
Corresponding author: Wohlfahrt, Patrick OncoRay, FWMP (HZDR)

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Zschaeck, S.; Löck, S.; Leger, S.; Haase, R.; Bandurska-Luque, A.; Appold, S.; Kotzerke, J.; Zips, D.; Richter, C.; Gudziol, V.; Schreiber, A.; Zöphel, K.; Baumann, M.; Krause, M.
Corresponding author: Zschaeck, Sebastian Uniklinikum Dresden

Targeting stem cells in radiation oncology
Coppes, R.; Dubrovska, A

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
Zindler, J.; Jochems, A.; Lagerwaard, F.; Beumer, R.; Troost, E.; Eekers, D.; Compter, I.; van der Toorn, P.-P.; Essers, M.; Oei, B.
Corresponding author: Zindler, Jd MAASTRO clinic

Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Wijsman, R.; Dankers, F.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L. F.; Bussink, J.

3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation
Eke, I.; Hehlgans, S.; Sandfort, V.; Cordes, N.
  • International Journal of Oncology 48(2016)1, 313-321

Ambidextrous Idea Generation-Antecedents and Outcomes
Gurtner, S.; Reinhardt, R.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baumann, M.; DKTK-ROG

A Compton camera prototype for prompt gamma medical imaging
Thirolf, P. G.; Aldawood, S.; Böhmer, M.; Bortfeldt, J.; Castelhano, I.; Dedes, G.; Fiedler, F.; Gernhäuser, R.; Golnik, C.; Helmbrecht, S.; Hueso-González, F.; von D. Kolff, H.; Kormoll, T.; Lang, C.; Liprandi, S.; Lutter, R.; Marinšek, T.; Maier, L.; Pausch, G.; Petzoldt, J.; Römer, K.; Schaart, D.; Parodi, K.

The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
Storch, K.; Cordes, N.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.
Offersen, B. V.; Boersma, L. J.; Kirkove, C.; Hol, S.; Aznar, M. C.; Sola, A. B.; Kirova, Y. M.; Pignol, J.-P.; Remouchamps, V.; Verhoeven, K.; Weltens, C.; Arenas, M.; Gabrys, D.; Kopek, N.; Krause, M.; Lundstedt, D.; Marinko, T.; Montero, A.; Yarnold, J.; Poortmans, P.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Linge, A.; Löck, S.; Krenn, C.; Appold, S.; Lohaus, F.; Nowak, A.; Gudziol, V.; Baretton, G. B.; Buchholz, F.; Baumann, M.; Krause, M.

Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter?
Lattermann, A.; Baumann, M.; Krause, M.

Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells
Dickreuter, E.; Eke, I.; Krause, M.; Borgmann, K.; van Vugt, M. A.; Cordes, N.

Bridging the valley of death: The new Radiotherapy & Oncology section “First in man - Translational innovations in radiation oncology.”
Baumann, M.; Overgaard, J.

Polyphenols delivery by polymeric materials: challenges in cancer treatment.
Vittorio, O.; Curcio, M.; Cojoc, M; Goya, G.; Hampel, S.; Iemma, F.; Dubrovska, A; Cirillo, G.

Nanoparticles for radiooncology: Mission, vision, challenges.
Kunz-Schughart, L.; Dubrovska, A.; Peitzsch, C.; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M.; Hampel, S.; Cirillo, G.; Iemmae, F.; Tietze, R.; Alexiou, C.; Stephan, H.; Zarschlerg, K.; Vittorio, O.; Kavallaris, M.; Parak, W.; Mädler, L.; Pokhrel, S.

Feasibility of proton pencil beam scanning treatment of free-breathing lung cancer patients
Jakobi, A.; Perrin, R.; Knopf, A.; Richter, C.ORC
Corresponding author: Jakobi, Annika OncoRay, Faculty of Medicine, University Hospital Dresden, TUD, HZDR

Nanoparticles for radiooncology: Mission, vision, challenges
Kunz-Schughart, L. A.; Dubrovska, A.; Peitzsch, C.; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M. H.; Hampel, S.; Cirillo, G.; Iemma, F.; Tietze, R.; Alexiou, C.; Stephan, H.ORC; Zarschler, K.; Vittorio, O.; Kavallaris, M.; Parak, W. J.; Mädler, L.; Pokhrel, S.

Toward Distributed Conduction of Large-Scale Studies in Radiation Therapy and Oncology: Open-Source System Integration Approach
Skripcak, T.; Just, U.; Simon, M.; Buttner, D.; Lühr, A.; Baumann, M.; Krause, M.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.
Linge, A.; Löck, S.; Gudziol, V.; Nowak, A.; Lohaus, F.; von Neubeck, C.; Jütz, M.; Abdollahi, A.; Debus, J.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Welz, S.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Baumann, M.; Krause, M.

Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
Wack, L. J.; Mönnich, D.; Yaromina, A.; Zips, D.; Baumann, M.; Thorwarth, D.

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Zegers, C. M. L.; Hoebers, F. J. P.; van Elmpt, W.; Bons, J. A.; Öllers, M. C.; Troost, E. G. C.; Eekers, D.; Balmaekers, L.; Arts-Pechtold, M.; Mottaghy, F. M.; Lambin, P.

Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch, C.; Bergmann, R.; Brüchner, K.; Mosch, B.; Yaromina, A.; Krause, M.; Zips, D.; Troost, E. G. C.; Löck, S.; Kotzerke, J.; Steinbach, J.; Thames, H.; Baumann, M.; Beuthien-Baumann, B.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge, A.; Lohaus, F.; Löck, S.; Nowak, A.; Gudziol, V.; Valentini, C.; von Neubeck, C.; Jütz, M.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Krause, M.; Baumann, M.

Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Eldesoky, A. R.; Yates, E. S.; Nyeng, T. B.; Thomsen, M. S.; Nielsen, H. M.; Poortmans, P.; Kirkove, C.; Krause, M.; Kamby, C.; Mjaaland, I.; Blix, E. S.; Jensen, I.; Berg, M.; Lorenzen, E. L.; Taheri-Kadkhoda, Z.; Offersen, B. V.

The Clinical Target Volume in Lung, Head-and-neck, and Esophageal Cancer: Lessons from Pathological Measurement and Recurrence Analysis
Apolle, R.ORC; Rehm, M.; Bortfeld, T.; Baumann, M.; Troost, E.

The cancer cell adhesion resistome: mechanisms, targeting and translational approaches
Dickreuter, E.; Cordes, N.
Corresponding author: Dickreuter, E.

Vertebral fractures – An underestimated side-effect in patients treated with radio(chemo)therapy
Pilz, K.; Hoffmann, A. L.; Baumann, M.; Troost, E. G. C.

Technical feasibility of integrating 7 T anatomical MRI in image‑guided radiotherapy of glioblastoma: a preparatory study
Compter, I.; Peerlings, J.; Eekers, D. B. P.; Postma, A. A.; Ivanov, D.; Wiggins, C. J.; Kubben, P.; Küsters, B.; Wesseling, P.; Ackermans, L.; Schijns, O. E. M. G.; Lambin, P.; Hoffmann, A. L.

Radiation oncology in the era of precision medicine
Baumann, M.; Krause, M.; Overgaard, J.; Debus, J.; Bentzen, S. M.; Daartz, J.; Richter, C.; Zips, D.; Bortfeld, T.

PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
Zschaeck, S.; Simon, M.; Löck, S.; Troost, E. G. C.; Stützer, K.; Wohlfahrt, P.; Appold, S.; Makocki, S.; Bütof, R.; Richter, C.; Baumann, M.; Krause, M.

Comment on „Dosimetric comparison of stopping power calibration with dual-energy CT and single-energy CT in proton therapy treatment planning“ [Med. Phys. 43(6), 2845-2854 (2016)]
Wohlfahrt, P.ORC; Möhler, C.ORC; Greilich, S.; Richter, C.
Corresponding author: Wohlfahrt, P. OncoRay, FWMP (HZDR)

Evaluation of a deformable registration algorithm for subsequent lung computed tomography imaging during radiochemotherapy
Stützer, K.; Haase, R.; Lohaus, F.; Barczyk, S.; Exner, F.; Löck, S.; Rühaak, J.; Lassen-Schmidt, B.; Corr, D.; Richter, C.

The Why and How of Amino Acid Analytics in Cancer Diagnostics and Therapy
Manig, F.; Kuhne, K.; von Neubeck, C.; Schwarzenbolz, U.; Yu, Z.; Kessler, B. M.; Pietzsch, J.; Kunz-Schughart, L. A.

Methodological accuracy of image-based electron-density assessment using dual-energy computed tomography
Möhler, C.ORC; Wohlfahrt, P.ORC; Richter, C.; Greilich, S.
Corresponding author: Wohlfahrt, Patrick OncoRay, Institut of Radiooncology (HZDR)

The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression
Tyutyunnykova, A.; Telegeev, G.; Dubrovska, A.
Corresponding author: Dubrovska, Anna HZDR, OncoRay, TU Dresden

Cancer stem cells: the root of tumor recurrence and metastases
Peitzsch, C.; Tyutyunnykova, A.; Pantel, K.; Dubrovska, A.
Corresponding author: Peitzsch, Claudia OncoRay - National Center for Radiation Research in Oncology, NCT

Superiority in robustness of multi-field optimization over single-field optimization for pencil-beam proton therapy for oropharynx carcinoma: an enhanced robustness analysis
Stützer, K.; Lin, A.; Kirk, M.; Lin, L.
Corresponding author: Stützer, Kristin Department of Radiation Oncology, University of Pennsylvania, Philadelphia; OncoRay; HZDR

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.
Martinussen, H. M. A.; Reymen, B.; Wanders, R.; Troost, E. G. C.; Dingemans, A.-M. C.; Öllers, M.; Houben, R.; de Ruysscher, D.; Lambin, P.; van Baardwijk, A.

Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy
Dankers, F.; Wijsman, R.; Troost, E.; Monshouwer, R.; Bussink, J.; Hoffmann, A.

Digital high-pass filter deconvolution by means of an infinite impulse response filter
Födisch, P.; Wohsmann, J.; Lange, B.; Schönherr, J.; Enghardt, W.; Kaever, P.

Charge-sensitive front-end electronics with operational amplifiers for CdZnTe detectors
Födisch, P.; Berthel, M.; Lange, B.; Kirschke, T.; Enghardt, W.; Kaever, P.

Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: incidence and proposed risk factors
Wink, K. C. J.; van Baardwijk, A.; Troost, E. G. C.; de Ruysscher, D.

Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin
Koppenhagen, P.; Dickreuter, E.; Cordes, N.
Corresponding author: Koppenhagen, P. TU Dresden

Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
Vanneste, B. G. L.; Hoffmann, A. L.; van Lin, E. N.; van de Voorde, L.; Pinkawa, M.; Lambin, P.

[18F]FDG-PET/CT based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches
de Jong, E.; van Elmpt, W.; Leijenaar, R.; Hoekstra, O.; Groen, H.; Smit, E.; Boellaard, R.; van der Noort, V.; Troost, E.; Lambin, P.; Dingemans, A.

Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial
Eekers, D. B. P.; Roelofs, E.; Jelen, U.; Kirk, M.; Granzier, M.; Ammazzalorso, F.; Ahn, P. H.; Janssens, G. O. R. J.; Hoebers, F. J. P.; Friedmann, T.; Solberg, T.; Walsh, S.; Troost, E. G. C.; Kaanders, J. H. A. M.; Lambin, P.

Clinical implementation of dual-energy CT for proton treatment planning on pseudo-monoenergetic CT scans
Wohlfahrt, P.; Möhler, C.; Hietschold, V.; Menkel, S.; Greilich, S.; Krause, M.; Baumann, M.; Enghardt, W.; Richter, C.

Range prediction for tissue mixtures based on dual-energy CT
Möhler, C.; Wohlfahrt, P.; Richter, C.; Greilich, S.

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC 3 prostate cancer in vitro and in vivo
Liebscher, S.; Koi, L.; Löck, S.; Muders, M. H.; Krause, M.
Corresponding author: Liebscher, Steffi
Corresponding author: Koi, Lydia
Corresponding author: Löck, Steffen
Corresponding author: Muders, M. H.
Corresponding author: Krause, Mechthild
  • Open Access LogoClinical and Translational Radiation Oncology (2017)

BEMER electromagnetic field therapy reduces cancer cell radioresistance by enhanced ROS formation and induced DNA damage
Storch, K.; Dickreuter, E.; Artati, A.; Adamski, J.; Cordes, N.
Corresponding author: Cordes, N.

Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
Wink, K. C. J.; Belderbos, J. S. A.; Dieleman, E. M. T.; Rossi, M.; Rasch, C. R. N.; Damhuis, R. A. M.; Houben, R. M. A.; Troost, E. G. C.

An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch, C.; Cojoc, M.; Hein, L.; Kurth, I.; Mäbert, K.; Trautmann, F.; Klink, B.; Schröck, E.; Wirth, M. P.; Krause, M.; Stakhovsky, E. A.; Telegeev, G. D.; Novotny, V.; Toma, M.; Muders, M.; Baretton, G. B.; Frame, F. M.; Maitland, N. J.; Baumann, M.; Dubrovska, A.

[Melanoma brain metastases : Treatment options]. [Hirnmetastasen des malignen Melanoms].
Rauschenberg, R.; Tabatabai, G.; Troost, E. G. C.; Garzarolli, M.; Beissert, S.; Meier, F.

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
Zscheppang, K.; Kurth, I.; Wachtel, N.; Dubrovska, A.; Kunz-Schughart, L. A.; Cordes, N.

Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk, B.; Schwager, C.; Deffaa, O.; Dyckhoff, G.; Warta, R.; Linge, A.; Krause, M.; Weichert, W.; Baumann, M.; Herold-Mende, C.; Debus, J.; Abdollahi, A.

Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation.
Carvalho, S.; Troost, E. G. C.; Bons, J.; Menheere, P.; Lambin, P.; Oberije, C.

Precise image-guided irradiation of small animals: a flexible non-profit platform
Tillner, F.; Thute, P.; Löck, S.; Dietrich, A.; Fursov, A.; Haase, R.; Lukas, M.; Rimarzig, B.; Sobiella, M.; Krause, M.; Baumann, M.; Bütof, R.; Enghardt, W.

Design and implementation of a robust and cost-effective double-scattering system at a horizontal proton beamline
Helmbrecht, S.; Baumann, M.; Fiedler, F.; Enghardt, W.; Krause, M.; Lühr, A.

Prediction and compensation of magnetic beam deflection in MR-integrated proton therapy: A method optimized regarding accuracy, versatility and speed
Schellhammer, S. M.; Hoffmann, A. L.

Stakeholder integration in new product development – A systematic analysis of drivers and firm capabilities
Martin, M. V.; Reinhardt, R.; Gurtner, S.

In-beam PET at clinical proton beams with pile-up rejection
Helmbrecht, S.; Enghardt, W.; Fiedler, F.; Iltzsche, M.; Pausch, G.; Tintori, C.; Kormoll, T.
Corresponding author: Helmbrecht, S.

How to catch the generation Y: Identifying consumers of ecological innovations among youngsters
Gurtner, S.; Soyez, K.

Prompt gamma rays detected with a BGO block Compton camera reveal range deviations of therapeutic proton beams
Hueso-González, F.; Pausch, G.; Petzoldt, J.; Römer, K. E.; Enghardt, W.

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.
Hofheinz, F.; Bütof, R.; Apostolova, I.; Zöphel, K.; Steffen, I. G.; Amthauer, H.; Kotzerke, J.; Baumann, M.; van den Hoff, J.
Corresponding author: Hofheinz, Frank Helmholtz-Zentrum Dresden-Rossendorf, PET Center, Institute of Radiopharmaceutical Cancer Research

Wertorientierung im Technologiemanagement von Krankenhäusern
Gurtner, S.; Gurtner, K.
  • mt-medizintechnik 2(2015), 57-60

Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer
Cobben, D. C. P.; de Boer, H. C. J.; Tijssen, R. H.; Rutten, E. G. G. M.; van Vulpen, M.; Peerlings, J.; Troost, E. G. C.; Hoffmann, A. L.; van Lier, A. L. H. M. W.

Magnetic Nanoparticles in tumour xenografts detected and quantified by Micro-Computer Tomography
Bayer, K.; Eckert, H.; Wiekhorst, F.; Trahms, L.; Krause, M.; Odenbach, S.

NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy
Jakobi, A.; Stützer, K.; Bandurska-Luque, A.; Löck, S.; Haase, R.; Wack, L.-J.; Mönnich, D.; Thorwarth, D.; Perez, D.; Lühr, A.; Zips, D.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C.

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicenter study of the German cancer consortium radiation oncology group (DKTK-ROG)
Balermpas, P.; Rödel, F.; Rödel, C.; Krause, M.; Linge, A.; Lohaus, F.; Baumann, M.; Tinhofer, I.; Budach, V.; Gkika, E.; Stuschke, M.; Avlar, M.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Bayer, C.; Stangl, S.; Belka, C.; Pigorsch, S.; Multhoff, G.; Combs, S. E.; Mönnich, D.; Zips, D.; Fokas, E.

Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy
Jakobi, A.; Lühr, A.; Stützer, K.; Bandurska-Luque, A.; Löck, S.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C.
Corresponding author: Krause, M. OncoRay; DKTK partner site Dresden; DKFZ; Strahlentherapie - Universitätsklinikum - Medizinische Fakultät; HZDR

A synchronous Gigabit Ethernet protocol stack for high-throughput UDP/IP applications
Födisch, P.; Lange, B.; Sandmann, J.; Büchner, A.; Enghardt, W.; Kaever, P.

Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI
Petr, J.; Platzek, I.; Seidlitz, A.; Mutsaerts, H. J. M. M.; Hofheinz, F.; Schramm, G.; Maus, J.; Beuthien-Baumann, B.; Krause, M.; van den Hoff, J.
Corresponding author: Petr, Jan

Stereotactic radiotherapy augments the immune response / Die stereotaktische Strahlentherapie unterstützt die Immunantwort
Troost, E. G. C.

Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake.
Trani, D.; Yaromina, A.; Dubois, L.; Granzier, M.; Peeters, S. G.; Biemans, R.; Nalbantov, G.; Lieuwes, N.; Reniers, B.; Troost, E. E.; Verhaegen, F.; Lambin, P.

HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.
Lohaus, F.; Linge, A.; Baumann, M.

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Kurth, I.; Hein, L.; Mäbert, K.; Peitzsch, C.; Koi, L.; Cojoc, M.; Kunz-Schughart, L.; Baumann, M.; Dubrovska, A.

Global Task Force on Radiotherapy for Cancer Control.
Jaffray, D. A.; Knaul, F. M.; Atun, R.; Adams, C.; Barton, M. B.; Baumann, M.; Lievens, Y.; Lui, T. Y.; Rodin, D. L.; Rosenblatt, E.; Torode, J.; van Dyk, J.; Vikram, B.; Gospodarowicz, M.

Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.
Hofheinz, F.; Lougovski, A.; Zöphel, K.; Hentschel, M.; Steffen, I. G.; Apostolova, I.; Wedel, F.; Buchert, R.; Baumann, M.; Brenner, W.; Kotzerke, J.; van den Hoff, J.

Proton therapy of pediatric rhabdomyosarcoma: Same tumor control as photon therapy, with less adverse effects / Protonentherapie von Rhabdomyosarkompatienten im Kindesalter: Gleiche lokale Tumorkontrolle wie bei Photonentherapie mit weniger Nebenwirkungen
Gurtner, K.; Baumann, M.

Comprehensive analysis of signal transduction in three-dimensional ECM-based tumor cell cultures.
Eke, I.; Hehlgans, S.; Zong, Y.; Cordes, N.

Cell-ECM interactions control DDR
Dickreuter, E.; Cordes, N.
  • Open Access LogoOncoscience 2(2015)8, 679-680

Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach, V.; Stromberger, C.; Poettgen, C.; Baumann, M.; Budach, W.; Grabenbauer, G.; Marnitz, S.; Olze, H.; Wernecke, K. D.; Ghadjar, P.

Expanding global access to radiotherapy
Atun, R.; Jaffray, D. A.; Barton, M. B.; Bray, F.; Baumann, M.; Vikram, B.; Hanna, T. P.; Knaul, F. M.; Lievens, Y.; Lui, T. Y.; Milosevic, M.; O'Sullivan, B.; Rodin, D. L.; Rosenblatt, E.; van Dyk, J.; Yap, M. L.; Zubizarreta, E.; Gospodarowicz, M.

Scintillator-Based High-Throughput Fast Timing Spectroscopy for Real-Time Range Verification in Particle Therapy
Pausch, G.; Petzoldt, J.; Berthel, M.; Enghardt, W.; Fiedler, F.; Golnik, C.; Hueso-González, F.; Lentering, R.; Römer, K.; Ruhnau, K.; Stein, J.; Wolf, A.; Kormoll, T.
  • IEEE Transactions on Nuclear Science 63(2016)2, 664-672
    DOI-Link: http://dx.doi.org/10.1109/TNS.2016.2527822
  • Lecture (Conference)
    13th International Conference on Scintillators and their Applications (SCINT), 07.-12.06.2015, Berkeley, USA

Approval procedures for clinical trials in the field of radiation oncology
Simon, M.; Habeck, M.; Büttner, D.; Habeck, U.; Nölling, T.; Krause, M.; Brix, G.; Willich, N.; Wenz, F.; Schmidberger, H.; Debus, J.; Baumann, M.

Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients
Wijsman, R.; Grootjans, W.; Troost, E. G.; van der Heijden, E. H.; Visser, E. P.; de Geus-Oei, L.-F.; Bussink, J.

First clinical application of a prompt gamma based in vivo proton range verification
Richter, C.; Pausch, G.; Barczyk, S.; Priegnitz, M.; Keitz, I.; Thiele, J.; Smeets, J.; Vander Stappen, F.; Bombelli, L.; Fiorini, C.; Hotoiu, L.; Perali, I.; Prieels, D.; Enghardt, W.; Baumann, M.

Imaging-Based Treatment Adaptation in Radiation Oncology
Troost, E. G.; Thorwarth, D.; Oyen, W. J.

Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?
Persoon, L. C.; Podesta, M.; Hoffmann, L.; Sanizadeh, A.; Schyns, L. E.; de Ruiter, B. M.; Nijsten, S. M.; Muren, L. P.; Troost, E. G.; Verhaegen, F.

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks, L. E.; Derks, J. L.; Postmus, P. E.; Damhuis, R. A.; Houben, R. M.; Troost, E. G.; Hochstenbag, M. M.; Smit, E. F.; Dingemans, A. M.

Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription
Zindler, J. D.; Thomas, C. R.; Hahn, S. M.; Hoffmann, A. L.; Troost, E. G. C.; Lambin, P.

Requirements for a Compton camera for in-vivo range verification of proton therapy
Rohling, H.; Priegnitz, M.; Schöne, S.; Schumann, A.; Enghardt, W.; Hueso-Gonzalez, F.; Pausch, G.; Fiedler, F.

Pages: [All] [1] [2]